I predict we won't up list until January or Februa

Quote:

---

I predict we won't up list until January or February 2015. I think we'll be above .25 to .30 cents by then. 1:12 to 1:18 Reverse Split.

The good news is LymPro will be a steady work horse for us. If we start in the .25 cent range in January, I see it rising to the $1.00 range by end of 2015 when the revenues really ramp up. Plus, we will have gotten Elto phase 2b results by then, and MANF human trials will be about to begin.

---

Just wanted to get you to clarify something. If we start 2015 at .25, then up list with a 1:12 or 1:18 reverse split, ($3-$4), how will the stock be rising to the $1.00 range by the end of 2015.

I think Gerald put the worry of the reverse split to bed. If it happens or not. Dilution will not happen because the O/S and A/S will move in tandem. I still believe we can make it without one, but a 1:2 or 1:3 R/S would get us to the share structure Amgen had before the big run in the 90's.

Great things ahead. This price is a gift at these levels. 2014 is not over yet so don't count it out. But if we have to wait a few months for big things, so be it. This is a long term investment for me.